Clinical Trial Update: Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update. Completion of a study evaluating zoledronic acid to prevent bone loss after kidney transplantation in patients with renal osteody…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Osteodystrophy

Drugs mentioned

• Zometa (Zoledronic acid)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Renal Osteodystrophy | Phase 4 | Status: COMPLETED